Shock is a life-threatening state commonly encountered by the acute physician. As such those practicing and training in the specialty should strive to become true experts in this field by going beyond even the learning provided by generic life support courses when involved with identifying and managing the shocked state. This article explores the current evidence, where it exists and provides a framework for approaching such patients along with common pitfalls.
[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]
References
- Emanuel Rivers, M.D., M.P.H., Bryant Nguyen, M.D., Suzanne Havstad et al for the Early Goal-Directed Therapy Collaborative Group. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock. N Engl J Med 2001; 345:1368-1377.
- Paul E. Marik, MD, FCCP; Michael Baram, MD, FCCP; Bobbak Vahid, M. Does Central Venous Pressure Predict Fluid Responsiveness?*: A Systematic Review of the Literature and the Tale of Seven Mares. Chest 2008;134(1):172-178.
- Chung HM, Kluge R, Schrier RW, Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987;83:905–8.
- Lichtenstein D. FALLS-protocol: lung ultrasound in hemodynamic assessment of shock. Heart, Lung and Vessels. 2013;5(3):142-147.
- David Blehar, Eitan Dickman, Romolo J Gaspari. Identification of congestive heart failure via respiratory variation of inferior vena cava diameter. The American journal of emergency medicine 2009 27(1):71-5
- Miller JB , Sen A , Strote SR, Hegg AJ. Inferior vena cava assessment in the bedside diagnosis of acute heart failure. The American Journal of Emergency Medicine 2012; 30(5):778-783
- ARDS-Net. Comparison of Two Fluid-Management Strategies in Acute Lung Injury. New England Journal of Medicine (2006);354:2564-75
- Bellomo R, Cass A, Cole L et al. RENAL Replacement Therapy Study Investigators. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med.2012 Jun;40(6):1753-60.
- Lanspa MJ, Grissom CK, Hirshberg EL et al. Applying dynamic parameters to predict hemodynamic response to volume expansion in spontaneously breathing patients with septic shock shock 2013; 39(2): 155–160.
- Muller L, Bobbia X, Toumi M et al. Respiratory variations of inferior vena cava diameter to predict fluid responsiveness in spontaneously breathing patients with acute circulatory failure: need for a cautious use. Crit Care 2012; 16(5): R188.
- Muller L, Toumi M, Bousquet PJ, et al; AzuRéa Group. An increase in aortic blood flow after an infusion of 100 ml colloid over 1 minute can predict fluid responsiveness: the mini-fluid challenge study.Anesthesiology 2011 Sep;115
- Perel P, Roberts I, Kerk K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;2
- Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012;367:124-134
- Hegarty C, Bellomo R, Yunos MN et al. Association between a Chloride-liberal versus Chloride Restrictive Intravenous Fluid and administration strategy and Acute Kidney Injury in Critically Ill adults JAMA 2012; 308(15): 1566-1572
- Young P, Bailey M, Beasley R et al. Effect of a buffered crystalloid solution versus saline on Acute Kidney Injury Among patients on the Intensive Care Unit. The SPLIT randomized clinical trial. JAMA 2015; 314(16): 1701-1710.
- The SAFE Study Investigators. A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. N Engl J Med 2004; 350:2247-2256
- Pietro C, Tognoni G, Masson S et al. Albumin Replacement in Patients with Severe Sepsis or Septic Shock. N Engl J Med 2014; 370:1412-1421
- Holcomb JB, Del Junco DJ, Fox EE et al; PROMMTT Study Group. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013;148(2):127-136
- Holcomb JB, Tilley BC, Baraniuk S, Fox EEJAMA. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 3;313(5):471-82
- Asfar P, Meziani F, Hamel JF et al for the SEPSISPAM Investigators. High versus Low Blood-Pressure Target in Patients with Septic Shock. N Engl J Med 2014; 370:1583-1593
- Mouncey PR, Osborn TM, Power GS et al for the ProMISe Trial Investigators. Trial of Early, Goal-Directed Resuscitation for Septic Shock. N Engl J Med 2015; 372:1301-1311
- The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-Directed Resuscitation for Patients with Early Septic Shock. N Engl J Med 2014; 371:1496-1506
- The ProCESS Investigators. A Randomized Trial of Protocol-Based Care for Early Septic Shock. N Engl J Med 2014; 370:1683-1693
- Jones A, Shapiro NI, Trzeciak S et al. Lactate clearance versus central venous oxygen saturation as goals of early sepsis therapy, a randomised clinical trial. JAMA 2010; 303:746-739(8)
- Hébert, PC, Wells G, Blajchman M.A et al. A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care. N Engl J Med 1999; 340:409-417
- Holst L.B, Haase, N, Wetterslev J, Wernerman J et al for the TRISS Trial Group and the Scandinavian Critical Care Trials Group. Lower versus Higher Haemoglobin Threshold for Transfusion in Septic Shock. N Engl J Med 2014; 371:1381-139
- Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 21;288(7):862-71.
- Sprung CL, Annane D, Keh D et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 10;358(2):111-24
- Russell JA, Walley KR, Singer J et al for the VASST Investigators. Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. N Engl J Med 2008; 358:877-887
- Thiele H, Zeymer U, Neumann F et al. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N Engl J Med 2012; 367(14): 1287-96
